About Well Shine
Founded in 1987, Well Shine Bio has deeply focused functional biotechnological raw materials for over 38 years.Driven by our core vision, "Returning to Nature, Innovating Sustainable Health," we translate decades of scientific research into innovative biopolymer materials defined by superior biocompatibility and full traceability.
In 2019, leveraging our proprietary Well Shine® Biopolymer, Well Shine Bio expanded into biomedical materials, emerging as a leading global supplier of non-animal-derived polymers.
We feature fully vertically integrated capabilities—from strain selection and scientific cultivation to patented extraction, purification, and end-application development. This end-to-end control ensures every stage aligns with strict global medical standards for quality, consistency, and supply chain resilience.Our state-of-the-art manufacturing facilities hold premier international certifications, including ISO 22000, HACCP, HALAL, and dietary supplement GMP, seamlessly supporting diverse global market demands.
Well Shine Bio’s biopolymers are successfully integrated into high-value sectors, including medical consumables and advanced non-woven composites, empowering global partners to boost product differentiation and sustainable competitiveness.
We are dedicated to setting safer, more transparent material standards for the biomedical industry—fusing the raw power of nature with cutting-edge technology to co-build a healthier future.
Addressing global aging and rising chronic care demands, Well Shine Bio focuses on high-value biomedical applications that elevate the safety and quality of clinical and home care.
To fuel long-term R&D and scale our international footprint, we will initiate our Initial Public Offering (IPO) process in Q4, 2026, targeting an Emerging Stock Board registration in 2027 to accelerate our integration into the global healthcare ecosystem.
Moving forward, Well Shine Bio will converge high-performance biomaterials with AI technology to pioneer precise, personalized care solutions, fulfilling our ultimate corporate mission: "Innovation, Sustainability, and Health."
Corporate Milestones
|
May 2026 |
Attained Health Supplement GMP Certification. |
|
Dec 2025 |
Secured Taiwan TFDA Class I Medical Device License. |
|
Nov 2025 |
Well Shine® Biopolymer honored with the 22nd National Innovation Award. |
|
Jul 2025 |
Signed a clinical collaboration agreement with the Innovation Incubation Center of Tri-Service General Hospital. |
|
2024 |
Manufacturing facilities achieved ISO 22000, HACCP, and Halal certifications; secured Medical Device Manufacturing License. |
|
2023 |
Manufacturing facilities secured Biotechnology Manufacturing License; Well Shine® Biopolymer successfully registered with INCI. |
|
2022 |
Officially entered the Yilan Park of Hsinchu Science Park. |
|
2020 |
Approved to join the Hsinchu Science Park following rigorous reviews by the NSTC, Academia Sinica, and NHRI. |
|
2019 |
Launched Well Shine® Biopolymer, officially entering the multi-billion biomaterials market. |
|
2016 |
Antrodia camphorata raw material passed the Taiwan Ministry of Health and Welfare (MOHW) safety review and received official clearance. |
|
Dr. Levin (USA) visited Taiwan to present breakthrough research on CavaTide®, Well Shine Bio’s patented Jack Bean extract. |
|
|
2014 |
Selected as an official supplier by international industry leaders, including Tenfu Group and Beijing Tong Ren Tang. |
|
2008 |
Co-hosted the International Symposium on Antrodia camphorata Research with Taipei Medical University and Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) |
|
2006 |
Selected by the Ministry of Economic Affairs (MOEA) to represent Taiwan at the BIO International Convention. |
|
2004 |
Received the MOEA Excellent Case Project Award and the 21st Century Quality Product Gold Medal; co-hosted an international symposium with Taipei Medical University. |
|
2003 |
Named an Outstanding Innovative R&D Enterprise by the Ministry of Economic Affairs (MOEA) |
|
2002 |
Honored with the National Biotechnology and Medical Care Quality Award. |
|
1999 |
Developed exclusive bio-cultivation technology for “Antrodia camphorata Fruiting Bodies," securing multiple national patents. |
|
1987-1993 |
Well Shine Biotechnology Development Co., Ltd. was established. |
